CMT&RIPNs are probably prevalent in older ages, males, and Northern Europe.
A meta-analysis on the prevalence of Charcot-Marie-Tooth disease and related inherited peripheral neuropathies
CONCLUSION: CMT&RIPNs are relatively more prevalent as CMT1 in the disease subtypes, and probably prevalent in older ages, males, and Northern Europe. More studies on the epidemiological characteristics of CMT&RIPNs with well-defined diagnosis criteria are needed to improve the prevalence evaluation and to arouse more attention to health care support.
J Neurol. 2023 Jan 11. doi: 10.1007/s00415-023-11559-8. Online ahead of print.
BACKGROUND: Charcot-Marie-Tooth disease and related inherited peripheral neuropathies (CMT&RIPNs) brings great suffering and heavy burden to patients, but its global prevalence rates have not been well described.
METHODS: We searched major English and Chinese databases for studies reporting the prevalence of CMT&RIPNs from the establishment of the databases to September 26, 2022. Based on the age, gender, study design, study region, and disease subtype, the included studies were correspondingly synthesized for meta-analyses on the overall prevalence and/or the subgroup analyses by using pool arcsine transformed proportions in the random-effects model.
RESULTS: Of the finally included 31 studies, 21 studied the whole age population and various types of CMT&RIPNs, and the others reported specific disease subtype(s) or adult or non-adult populations. The pooled prevalence was 17.69/100,000 (95% CI 12.32-24.33) for the whole age population and significantly higher for CMT1 [10.61/100,000 (95% CI 7.06-14.64)] than for other subtypes (P’ < 0.001). Without statistical significance, the prevalence seemed higher in those aged ≥ 16 or 18 years (21.02/100,000) than in those aged < 16 years (16.13/100,000), in males (22.50/100,000) than in females (17.95/100,000), and in Northern Europe (30.97/100,000) than in other regions. CONCLUSION: CMT&RIPNs are relatively more prevalent as CMT1 in the disease subtypes, and probably prevalent in older ages, males, and Northern Europe. More studies on the epidemiological characteristics of CMT&RIPNs with well-defined diagnosis criteria are needed to improve the prevalence evaluation and to arouse more attention to health care support. PMID:36631678 | DOI:10.1007/s00415-023-11559-8 SOURCE: Journal of neurology TAGS: CMTRIPNs CATEGORY: Research SUBCATEGORY: n/a DATE - PUBLISHED: 2023-01-11T17:09:25Z DATE - DOI: 2023-01-11T17:09:25Z DATE - PUBMED: 2023 Jan 11 DATE OUTPUT MATCHED: True DATE - ADDED: Wed, 11 Jan 2023 06:00:00 -0500 DATE - RETRIEVED: 01/12/23 01:03AM 2023-01-12T01:03:04-05:00 FEATURED IMAGE: Media Uploaded (image/png) IDENTIFIER: pmid:36631678,doi:10.1007/s00415-023-11559-8 PUBMED ID: pubmed:36631678 DOI: 10.1007/s00415-023-11559-8 LINK - PUBMED: https://pubmed.ncbi.nlm.nih.gov/36631678/ LINK - DOI: https://doi.org/10.1007/s00415-023-11559-8 LINK - PUBLISHER: https://link.springer.com/10.1007/s00415-023-11559-8 REFERENCES: CMT Treatment Report, Urgent Research, 2023-01-12T01:03:04-05:00, https://www.cmttreatmentreport.com.